Abstract

Few data are available on the circadian rhythmicity in cancer patients. Since monitoring the disease usually implies the follow-up of blood concentrations of a number of biological variables, it would be of value to examine the profile of the circadian variations of serum cortisol and tumour marker antigens. This we did in 33 cancer patients (13 breast cancer patients and 20 ovarian cancer patients). The profiles of serum cortisol were documented, since this hormone is considered as a strong marker of circadian rhythms. This study shows that 8 out of 13 breast cancer patients and 15 out of 20 ovarian cancer patients had deeply altered cortisol circadian patterns. The modifications were either high levels along the 24 h scale and/or erratic peaks and troughs and/or flattened profiles. Within 24 h, variations of tumour marker antigens as large as 70% were observed but no typical individual circadian patterns could be found. No relationship between cortisol subgroups and concentration of tumour marker antigens at 8 h could be observed (Kolmogorov-Smirnov's test). The question thus arises as to the origin of these alterations, and whether they are related to a cause or a consequence of the disease, and their possible incidence upon therapeutic designs.

Highlights

  • We examined the circadian profiles of serum cortisol since this hormone is considered as a strong marker of circadian rhythms in humans (Haus and Touitou, 1994)

  • Serum cortisol was determined by radioimmunoassay (RIA) (Travenol, Paris)

  • Serum carcinoembryonic antigen (CEA) and CA 125 were determined by enzyme immunoassay (EIA) (Abbott, Rungis, France) and serum CA 15-3 by Immunoradiometric assay (IRMA) (CIS biointernational, Gif-sur-Yvette, France)

Read more

Summary

Methods

Blood samples were taken only every 4 h over 24 h for each patient; they were allowed to clot and the serum was aspirated, aliquoted and frozen at -200C until analysed. Individual profiles were drawn after classifying the subjects into subgroups with high and low serum levels of tumour marker antigens on the one hand and according to so-called normal and abnormal circadian profiles of serum cortisol on the other hand. A circadian profile of serum cortisol was considered as normal when it displayed a high morning concentration around 08.00, and a decline with the lowest concentrations between 20.00 and 00.00. It was considered as abnormal when it was, for example, constantly high or low or presented erratic peaks or troughs

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.